Literature DB >> 7874271

Use of immobilized histidine in assay for endotoxin in patients with liver disease.

S Shiomi1, T Kuroki, T Ueda, T Takeda, S Nishiguchi, S Nakajima, K Kobayashi, S Yamagami, T Watanabe, S Minobe.   

Abstract

The Limulus amebocyte lysate (LAL) test has the disadvantage of being influenced by various inhibitors and activators. We have developed a method for the LAL reaction that involves the specific adsorption and isolation of endotoxin using a membrane filter unit and immobilized histidine; in this present study we used the method to measure endotoxin in the plasma of patients with acute or chronic liver disease. The adsorbed endotoxins are separated from LAL-inhibitors or -activators by the membrane filter unit, and their activity is directly assayed with the LAL reagent in a filter cup without any inhibition or activation. The study population consisted of 23 subjects, 3 with fulminant hepatitis and 20 with cirrhosis (9 with esophageal varices and 11 without). All 3 (100%) of the samples of plasma from patients with fulminant hepatitis were positive for endotoxin, as were the samples of 7 (78%) of the 9 patients with cirrhosis and esophageal varices, and 2 (18%) of the 11 patients with cirrhosis but without such varices. The results suggested that this method appears to be useful for assaying the concentration of endotoxin in patients with fulminant hepatitis or cirrhosis of the liver.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874271     DOI: 10.1007/bf02349282

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  10 in total

1.  Specific assay for endotoxin using immobilized histidine, Limulus amoebocyte lysate and a chromogenic substrate.

Authors:  M Nawata; S Minobe; M Hase; T Watanabe; T Sato; T Tosa
Journal:  J Chromatogr       Date:  1992-04-24

2.  Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance.

Authors:  K Tarao; K So; T Moroi; T Ikeuchi; T Suyama
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

3.  A new perchloric acid treatment of human plasma for detection of endotoxin by an endotoxin-specific chromogenic test.

Authors:  K Inada; M Yoshida; T Takahashi; S Tamura; S Tanaka; S Endo; T Yoshida; H Suda; T Komuro
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

4.  [Study on the cause of elevated total serum immunoglobulin M in patients with acute hepatitis A].

Authors:  H Nakano
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1987-09

5.  Endotoxaemia in man.

Authors:  D T Caridis; R B Reinhold; P W Woodruff; J Fine
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

6.  Detection of endotoxin in human blood and demonstration of an inhibitor.

Authors:  J Levin; P A Tomasulo; R S Oser
Journal:  J Lab Clin Med       Date:  1970-06

7.  Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria.

Authors:  J Levin; T E Poore; N P Zauber; R S Oser
Journal:  N Engl J Med       Date:  1970-12-10       Impact factor: 91.245

8.  A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications.

Authors:  T Obayashi; H Tamura; S Tanaka; M Ohki; S Takahashi; M Arai; M Masuda; T Kawai
Journal:  Clin Chim Acta       Date:  1985-06-30       Impact factor: 3.786

9.  In vitro studies of intestinal endotoxin absorption. I. Kinetics of absorption in the isolated everted gut sac.

Authors:  J P Nolan; D K Hare; J J McDevitt; M V Ali
Journal:  Gastroenterology       Date:  1977-03       Impact factor: 22.682

10.  [The study of endotoxin levels in portal venous system in liver cirrhosis].

Authors:  Y Yamamoto; S Sezai; S Sakurabayashi; K Yoshiura; S Sanui; T Morita; T Shimizu; K Yoshino; T Iwase; M Hirano
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1990-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.